Cargando…

Comparison of two immunoassays for the measurement of serum HE4 for ovarian cancer

INTRODUCTION: The use of Human Epididymis Protein 4 (HE4) as a biomarker for ovarian cancer is gaining traction, providing the impetus for development of a high throughput automated HE4 assay that is comparable to the conventional manual enzyme immunometric-assay (EIA). The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barr, Chloe E., Funston, Garth, Mounce, Luke T.A., Pemberton, Phillip W., Howe, Jonathon D., Crosbie, Emma J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138765/ https://www.ncbi.nlm.nih.gov/pubmed/34036134 http://dx.doi.org/10.1016/j.plabm.2021.e00235

Ejemplares similares

The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population
por: Barr, Chloe E., et al.
Publicado: (2022)

CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records
por: Funston, Garth, et al.
Publicado: (2021)

Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
por: Barr, Chloe E., et al.
Publicado: (2023)

Detecting ovarian cancer in primary care: can we do better?
por: Funston, Garth, et al.
Publicado: (2022)

HE4 as a Biomarker for Endometrial Cancer
por: Behrouzi, Roya, et al.
Publicado: (2021)

Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features
por: Barr, Chloe E., et al.
Publicado: (2022)

Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer
por: Behrouzi, Roya, et al.
Publicado: (2020)

The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study
por: Funston, Garth, et al.
Publicado: (2020)

Could Ovarian Cancer Prediction Models Improve the Triage of Symptomatic Women in Primary Care? A Modelling Study Using Routinely Collected Data
por: Funston, Garth, et al.
Publicado: (2021)

Identifying Ovarian Cancer in Symptomatic Women: A Systematic Review of Clinical Tools
por: Funston, Garth, et al.
Publicado: (2020)

Pre-diagnostic clinical features and blood tests in patients with colorectal cancer: a retrospective linked-data study
por: Moullet, Marie, et al.
Publicado: (2022)

Urine CA125 and HE4 for the Triage of Symptomatic Women with Suspected Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2022)

Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125
por: Chudecka-Głaz, Anita, et al.
Publicado: (2016)

Recognizing Gynecological Cancer in Primary Care: Risk Factors, Red Flags, and Referrals
por: Funston, Garth, et al.
Publicado: (2018)

Correction to: Recognizing Gynecological Cancer in Primary Care: Risk Factors, Red Flags, and Referrals
por: Funston, Garth, et al.
Publicado: (2018)

Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines
por: Funston, Garth, et al.
Publicado: (2019)

Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2020)

Urinary biomarkers for the detection of ovarian cancer: a systematic review
por: Owens, Gemma L, et al.
Publicado: (2022)

The promotion of academic medicine through student-led initiatives
por: Funston, Garth
Publicado: (2015)

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
por: Huhtinen, K, et al.
Publicado: (2009)

Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay
por: Horala, Agnieszka, et al.
Publicado: (2017)

Reference Values for IGF-I Serum Concentrations: Comparison of Six Immunoassays
por: Chanson, Philippe, et al.
Publicado: (2016)

Comparative study of two immunoassays used for the determination of serum vitamin D
por: Lahoz, Raquel, et al.
Publicado: (2021)

Current and Emerging Prognostic Biomarkers in Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2022)

The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer
por: WEI, SU, et al.
Publicado: (2016)

Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125
por: Bayoumy, Sherif, et al.
Publicado: (2020)

Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women
por: Cho, Hye Yon, et al.
Publicado: (2015)

Comparison of two malaria multiplex immunoassays that enable quantification of malaria antigens
por: Jang, Ihn Kyung, et al.
Publicado: (2022)

Cancer incidence following a high-normal platelet count: cohort study using electronic healthcare records from English primary care
por: Mounce, Luke TA, et al.
Publicado: (2020)

SAT-355 Comparison of Two Serum Cortisol Immunoassays versus Liquid Chromatography: Tandem Mass Spectrometry (LC-MS/MS)
por: Brito, Luciana, et al.
Publicado: (2019)

Diagnosis and preoperative predictive value of serum HE4 concentrations for optimal debulking in epithelial ovarian cancer
por: YANG, ZHIJUN, et al.
Publicado: (2013)

Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses
por: Dewan, Rupali, et al.
Publicado: (2019)

Quantitative immunoassay for mink immunoglobulin in serum and milk
por: Mathiesen, Ronja, et al.
Publicado: (2018)

The changing face of missed appointments
por: Parsons, Jo, et al.
Publicado: (2023)

Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A prospective database analysis
por: Njoku, Kelechi, et al.
Publicado: (2022)

Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4
por: O’Shannessy, Daniel J, et al.
Publicado: (2013)

Multicenter comparison of automated procalcitonin immunoassays
por: Dipalo, Mariella, et al.
Publicado: (2015)

The two pragmatisms : from Peirce to Rorty /
por: Mounce, H. O.
Publicado: (1997)

The Comparison Between Different Immunoassays for Serum Carbohydrate Antigen (CA 19-9) Concentration Measurement
por: Serdarevic, Nafija
Publicado: (2018)

HE4, CA-125, and cystic ovarian mass
por: Wiwanitkit, Viroj
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_drib63mc16pkdked56tq1on42j